The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
The role of nanotechnology in the treatment of viral infections
Open accessAbstract
Infectious diseases are the leading cause of mortality worldwide, with viruses in particular making global impact on healthcare and socioeconomic development. In addition, the rapid development of drug resistance to currently available therapies and adverse side effects due to prolonged use is a serious public health concern. The development of novel treatment strategies is therefore required. The interaction of nanostructures with microorganisms is fast-revolutionizing the biomedical field by offering advantages in both diagnostic and therapeutic applications. Nanoparticles offer unique physical properties that have associated benefits for drug delivery. These are predominantly due to the particle size (which affects bioavailability and circulation time), large surface area to volume ratio (enhanced solubility compared to larger particles), tunable surface charge of the particle with the possibility of encapsulation, and large drug payloads that can be accommodated. These properties, which are unlike bulk materials of the same compositions, make nanoparticulate drug delivery systems ideal candidates to explore in order to achieve and/or improve therapeutic effects. This review presents a broad overview of the application of nanosized materials for the treatment of common viral infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions
FRENS, G. (1973) · Nature Physical Science · doi:10.1038/physci241020a0 · Cited by 8,336
A study of the nucleation and growth processes in the synthesis of colloidal gold
Turkevich, J., Stevenson, P. C., & Hillier, J. (1951) · Discussions of the Faraday Society · doi:10.1039/df9511100055 · Cited by 7,792
Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid–Liquid system
Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., & Whyman, R. (1994) · J. Chem. Soc., Chem. Commun. · doi:10.1039/c39940000801 · Cited by 6,707
Silver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Ghosh Chaudhuri, R., & Paria, S. (2012) · Chemical Reviews · doi:10.1021/cr100449n · Cited by 3,614
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Preparation and Characterization of Au Colloid Monolayers
Grabar, K. C., Freeman, R. G., Hommer, M. B., & Natan, M. J. (1995) · Analytical Chemistry · doi:10.1021/ac00100a008 · Cited by 2,756
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Biological synthesis of metallic nanoparticles
Thakkar, K. N., Mhatre, S. S., & Parikh, R. Y. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.07.002 · Cited by 2,394
Monolayer-Protected Cluster Molecules
Templeton, A. C., Wuelfing, W. P., & Murray, R. W. (2000) · Accounts of Chemical Research · doi:10.1021/ar9602664 · Cited by 2,392
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Complement and its role in innate and adaptive immune responses
Dunkelberger, J. R., & Song, W.-C. (2010) · Cell Research · doi:10.1038/cr.2009.139 · Cited by 1,932
Large clusters and colloids. Metals in the embryonic state
Schmid, G. (1992) · Chemical Reviews · doi:10.1021/cr00016a002 · Cited by 1,867
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Polymer-based nanocapsules for drug delivery
Mora-Huertas, C. E., Fessi, H., & Elaissari, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.018 · Cited by 1,742
Ion Release Kinetics and Particle Persistence in Aqueous Nano-Silver Colloids
Liu, J., & Hurt, R. H. (2010) · Environmental Science & Technology · doi:10.1021/es9035557 · Cited by 1,655
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Khlebtsov, N., & Dykman, L. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00018c · Cited by 1,584
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Neumann, G., Noda, T., & Kawaoka, Y. (2009) · Nature · doi:10.1038/nature08157 · Cited by 1,561
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Herpes simplex virus infections
Whitley, R. J., & Roizman, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04638-9 · Cited by 1,366
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Handbook of nanostructured materials and nanotechnology
Nalwa, H. S. (2000) · Cited by 1,189
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Letchford, K., & Burt, H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,143
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Molecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Mode of antiviral action of silver nanoparticles against HIV-1
Lara, H. H., Ayala-Nuñez, N. V., Ixtepan-Turrent, L., & Rodriguez-Padilla, C. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-1 · Cited by 1,061
Nanostructured materials for applications in drug delivery and tissue engineering
Goldberg, M., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,054
The Influenza Virus Resource at the National Center for Biotechnology Information
Bao, Y., Bolotov, P., Dernovoy, D., Kiryutin, B., Zaslavsky, L., Tatusova, T., Ostell, J., & Lipman, D. (2008) · Journal of Virology · doi:10.1128/jvi.02005-07 · Cited by 995
Antifungal activity of silver nanoparticles against Candida spp.
Panáček, A., Kolář, M., Večeřová, R., Prucek, R., Soukupová, J., Kryštof, V., Hamal, P., Zbořil, R., & Kvítek, L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.065 · Cited by 964
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
The study of antimicrobial activity and preservative effects of nanosilver ingredient
Cho, K.-H., Park, J.-E., Osaka, T., & Park, S.-G. (2005) · Electrochimica Acta · doi:10.1016/j.electacta.2005.04.071 · Cited by 938
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli
Cui, Y., Zhao, Y., Tian, Y., Zhang, W., Lü, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.057 · Cited by 862
Flexner, C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 852
Effect of Gold Nanoparticle Aggregation on Cell Uptake and Toxicity
Albanese, A., & Chan, W. C. W. (2011) · ACS Nano · doi:10.1021/nn2007496 · Cited by 847
Multifunctional nanoparticles – properties and prospects for their use in human medicine
Sanvicens, N., & Marco, M. P. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.005 · Cited by 833
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds
Lara, H. H., Garza-Treviño, E. N., Ixtepan-Turrent, L., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-30 · Cited by 741
Buccal bioadhesive drug delivery — A promising option for orally less efficient drugs
Sudhakar, Y., Kuotsu, K., & Bandyopadhyay, A. K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.012 · Cited by 724
Nanotoxicity: the growing need for in vivo study
Fischer, H. C., & Chan, W. C. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.11.008 · Cited by 717
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., & Si-Tahar, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410592200 · Cited by 689
Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Blanken, M. O., Rovers, M. M., Molenaar, J. M., Winkler-Seinstra, P. L., Meijer, A., Kimpen, J. L. L., & Bont, L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211917 · Cited by 671
Cationic TAT peptide transduction domain enters cells by macropinocytosis
Kaplan, I. M., Wadia, J. S., & Dowdy, S. F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.018 · Cited by 668
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
FDA-approved poly(ethylene glycol)–protein conjugate drugs
Alconcel, S. N. S., Baas, A. S., & Maynard, H. D. (2011) · Polymer Chemistry · doi:10.1039/c1py00034a · Cited by 643
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Champion, J. A., & Mitragotri, S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9626-z · Cited by 617
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Core/shell nanoparticles in biomedical applications
Chatterjee, K., Sarkar, S., Jagajjanani Rao, K., & Paria, S. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.12.008 · Cited by 610
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
Wagner, R., Matrosovich, M., & Klenk, H. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.352 · Cited by 608
Preparation and antibacterial activity of Fe3O4@Ag nanoparticles
Gong, P., Li, H., He, X., Wang, K., Hu, J., Tan, W., Zhang, S., & Yang, X. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/28/285604 · Cited by 599
Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Bioactivity, mechanism of action, and cytotoxicity of copper-based nanoparticles: A review
Ingle, A. P., Duran, N., & Rai, M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5422-8 · Cited by 577
Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., Mitragotri, S., & Muzykantov, V. R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.127 · Cited by 564
Vaccine delivery using nanoparticles
Gregory, A. E., Titball, R., & Williamson, D. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00013 · Cited by 561
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., & Labhasetwar, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00328-6 · Cited by 529
Towner, J. S., Rollin, P. E., Bausch, D. G., Sanchez, A., Crary, S. M., Vincent, M., Lee, W. F., Spiropoulou, C. F., Ksiazek, T. G., Lukwiya, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4330-4341.2004 · Cited by 515
Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages
Kuhn, D. A., Vanhecke, D., Michen, B., Blank, F., Gehr, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2014) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.5.174 · Cited by 513
Elliott, J. H., Wightman, F., Solomon, A., Ghneim, K., Ahlers, J., Cameron, M. J., Smith, M. Z., Spelman, T., McMahon, J., Velayudham, P., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004473 · Cited by 504
Fätkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I. M., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1319 · Cited by 495
Laser‐Induced Release of Encapsulated Materials inside Living Cells
Skirtach, A. G., Muñoz Javier, A., Kreft, O., Köhler, K., Piera Alberola, A., Möhwald, H., Parak, W. J., & Sukhorukov, G. B. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504599 · Cited by 492
Global Transmission of Oseltamivir-Resistant Influenza
Moscona, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0900648 · Cited by 469
Geisbert, T. W., Lee, A. C., Robbins, M., Geisbert, J. B., Honko, A. N., Sood, V., Johnson, J. C., de Jong, S., Tavakoli, I., Judge, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60357-1 · Cited by 463
Laser‐Induced Release of Encapsulated Materials inside Living Cells
Skirtach, A. G., Muñoz Javier, A., Kreft, O., Köhler, K., Piera Alberola, A., Möhwald, H., Parak, W. J., & Sukhorukov, G. B. (2006) · Angewandte Chemie · doi:10.1002/ange.200504599 · Cited by 455
Current progress of siRNA/shRNA therapeutics in clinical trials
Burnett, J. C., Rossi, J. J., & Tiemann, K. (2011) · Biotechnology Journal · doi:10.1002/biot.201100054 · Cited by 444
DeVincenzo, J., Lambkin-Williams, R., Wilkinson, T., Cehelsky, J., Nochur, S., Walsh, E., Meyers, R., Gollob, J., & Vaishnaw, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 442
Sun, R. W.-Y., Chen, R., Chung, N. P.-Y., Ho, C.-M., Lin, C.-L. S., & Che, C.-M. (2005) · Chemical Communications · doi:10.1039/b510984a · Cited by 440
Complement activation and protein adsorption by carbon nanotubes
SALVADORMORALES, C., FLAHAUT, E., SIM, E., SLOAN, J., HGREEN, M., & SIM, R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.02.006 · Cited by 434
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Saleh, N. B., Pfefferle, L. D., & Elimelech, M. (2008) · Environmental Science & Technology · doi:10.1021/es801251c · Cited by 429
Kettler, K., Veltman, K., van de Meent, D., van Wezel, A., & Hendriks, A. J. (2013) · Environmental Toxicology and Chemistry · doi:10.1002/etc.2470 · Cited by 410
Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products
Fruijtier-Pölloth, C. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.001 · Cited by 407
de Béthune, M.-P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 401
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Cihlar, T., & Ray, A. S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.014 · Cited by 375
Galdiero, S., Rai, M., Gade, A., Falanga, A., Incoronato, N., Russo, L., Galdiero, M., Gaikwad, S., & Ingle, A. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s50070 · Cited by 373
Inhibition of HIV Fusion with Multivalent Gold Nanoparticles
Bowman, M.-C., Ballard, T. E., Ackerson, C. J., Feldheim, D. L., Margolis, D. M., & Melander, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710321g · Cited by 371
Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., & Bramwell, V. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.036 · Cited by 333
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
Shafer, R. W., Rhee, S.-Y., Pillay, D., Miller, V., Sandstrom, P., Schapiro, J. M., Kuritzkes, D. R., & Bennett, D. (2007) · AIDS · doi:10.1097/qad.0b013e328011e691 · Cited by 324
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., & Liang, X.-J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.058 · Cited by 315
Zika virus is a global public health emergency, declares WHO
Gulland, A. (2016) · BMJ · doi:10.1136/bmj.i657 · Cited by 303
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells
Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W., & Unutmaz, D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020198 · Cited by 301
Characterization of dendrimers
CAMINADE, A., LAURENT, R., & MAJORAL, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.011 · Cited by 297
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.029 · Cited by 292
Lei, R., Wu, C., Yang, B., Ma, H., Shi, C., Wang, Q., Wang, Q., Yuan, Y., & Liao, M. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.026 · Cited by 291
Nanotechnology applied to the treatment of malaria
Santos-Magalhães, N. S., & Mosqueira, V. C. F. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.024 · Cited by 286
Balfour, H. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401608 · Cited by 285
Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
Kingsley, J. D., Dou, H., Morehead, J., Rabinow, B., Gendelman, H. E., & Destache, C. J. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9032-4 · Cited by 280
Current status and challenges of antiretroviral research and therapy
Esté, J. A., & Cihlar, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277
Production and clinical development of nanoparticles for gene delivery
Chen, J., Guo, Z., Tian, H., & Chen, X. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.23 · Cited by 274
Zook, J. M., MacCuspie, R. I., Locascio, L. E., Halter, M. D., & Elliott, J. T. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.536615 · Cited by 265
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles
Sulheim, E., Baghirov, H., von Haartman, E., Bøe, A., Åslund, A. K. O., Mørch, Y., & Davies, C. D. L. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0156-7 · Cited by 262
Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide
Münch, J., Ständker, L., Adermann, K., Schulz, A., Schindler, M., Chinnadurai, R., Pöhlmann, S., Chaipan, C., Biet, T., Peters, T., et al. (2007) · Cell · doi:10.1016/j.cell.2007.02.042 · Cited by 261
Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?
Hayden, F. (2009) · Clinical Infectious Diseases · doi:10.1086/591851 · Cited by 256
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
Mamo, T., Moseman, E. A., Kolishetti, N., Salvador-Morales, C., Shi, J., Kuritzkes, D. R., Langer, R., Andrian, U. V., & Farokhzad, O. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.1 · Cited by 255
Targeting C-type lectin receptors with multivalent carbohydrate ligands
Lepenies, B., Lee, J., & Sonkaria, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.007 · Cited by 251
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
Thi, E. P., Mire, C. E., Lee, A. C. H., Geisbert, J. B., Zhou, J. Z., Agans, K. N., Snead, N. M., Deer, D. J., Barnard, T. R., Fenton, K. A., et al. (2015) · Nature · doi:10.1038/nature14442 · Cited by 249
Therapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat-Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 242
Chen, B.-M., Su, Y.-C., Chang, C.-J., Burnouf, P.-A., Chuang, K.-H., Chen, C.-H., Cheng, T.-L., Chen, Y.-T., Wu, J.-Y., & Roffler, S. R. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03109 · Cited by 239
Rupp, R. E., Rosenthal, S. L., & Stanberry, L. R. (2007) · PubMed · Cited by 235
Treatment of herpes simplex virus infections
Brady, R. C., & Bernstein, D. I. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.006 · Cited by 233
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
Bovier, P. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1141 · Cited by 233
Richter, A. W., & Åkerblom, E. (1984) · International Archives of Allergy and Immunology · doi:10.1159/000233512 · Cited by 229
Targeted Nanomedicines: Effective Treatment Modalities for Cancer, AIDS and Brain Disorders
Muthu, M. S., & Singh, S. (2009) · Nanomedicine · doi:10.2217/17435889.4.1.105 · Cited by 225
TAT Peptide Internalization: Seeking the Mechanism of Entry
Vives, E., Richard, J., Rispal, C., & Lebleu, B. (2003) · Current Protein & Peptide Science · doi:10.2174/1389203033487306 · Cited by 225
Barbaro, G., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764869 · Cited by 222
Potential neurotoxicity of nanoparticles
Hu, Y.-L., & Gao, J.-Q. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.026 · Cited by 213
Orlowski, P., Tomaszewska, E., Gniadek, M., Baska, P., Nowakowska, J., Sokolowska, J., Nowak, Z., Donten, M., Celichowski, G., Grobelny, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104113 · Cited by 211
RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
Zamora, M. R., Budev, M., Rolfe, M., Gottlieb, J., Humar, A., DeVincenzo, J., Vaishnaw, A., Cehelsky, J., Albert, G., Nochur, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0422oc · Cited by 210
Poon, Z., Lee, J. B., Morton, S. W., & Hammond, P. T. (2011) · Nano Letters · doi:10.1021/nl200636r · Cited by 205
Proteases of the complement system
Sim, R. B., & Tsiftsoglou, S. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320021 · Cited by 202
Antoine, T. E., Mishra, Y. K., Trigilio, J., Tiwari, V., Adelung, R., & Shukla, D. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.09.020 · Cited by 195
Polymersome Encapsulated Hemoglobin: A Novel Type of Oxygen Carrier
Arifin, D. R., & Palmer, A. F. (2005) · Biomacromolecules · doi:10.1021/bm0501454 · Cited by 192
Silver Nanoparticles Inhibit Replication of Respiratory Syncytial Virus
Sun, L., Singh, A. K., Vig, K., Pillai, S. R., & Singh, S. R. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.012 · Cited by 189
Xu, H., Yan, F., Monson, E. E., & Kopelman, R. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10057 · Cited by 187
Lembo, D., Swaminathan, S., Donalisio, M., Civra, A., Pastero, L., Aquilano, D., Vavia, P., Trotta, F., & Cavalli, R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.12.031 · Cited by 184
Inflexal®V a trivalent virosome subunit influenza vaccine: production
Mischler, R., & Metcalfe, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00512-1 · Cited by 183
Nanoparticles: Cellular Uptake and Cytotoxicity
Adjei, I. M., Sharma, B., & Labhasetwar, V. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-8739-0_5 · Cited by 182
Uskokovic, D., & Stevanovic, M. (2009) · Current Nanoscience · doi:10.2174/157341309787314566 · Cited by 182
Yadavalli, T., & Shukla, D. (2017) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.08.016 · Cited by 178
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS
Nair, M., Jayant, R. D., Kaushik, A., & Sagar, V. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.008 · Cited by 176
Lee, M.-Y., Yang, J.-A., Jung, H. S., Beack, S., Choi, J. E., Hur, W., Koo, H., Kim, K., Yoon, S. K., & Hahn, S. K. (2012) · ACS Nano · doi:10.1021/nn302538y · Cited by 175
Li, Y., Lin, Z., Zhao, M., Xu, T., Wang, C., Hua, L., Wang, H., Xia, H., & Zhu, B. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06613 · Cited by 175
In vivo delivery of RNAi with lipid-based nanoparticles
Huang, L., & Liu, Y. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124709 · Cited by 174
New perspectives in nanomedicine
Thorley, A. J., & Tetley, T. D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.008 · Cited by 171
Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages
Yu, S., Lau, Thomas, Jerome, Dickerson, Giorgio, T., Hubbell, & Maron (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28531 · Cited by 171
Surface Chemistry of Gold Nanoparticles Mediates Their Exocytosis in Macrophages
Oh, N., & Park, J.-H. (2014) · ACS Nano · doi:10.1021/nn501668a · Cited by 171
Taylor, T. (2002) · Frontiers in Bioscience · doi:10.2741/taylor · Cited by 166
Integrase, LEDGF/p75 and HIV replication
Poeschla, E. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7540-5 · Cited by 165
Borel, T., & Sabliov, C. M. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030713-092354 · Cited by 165
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
Dunning, J., Sahr, F., Rojek, A., Gannon, F., Carson, G., Idriss, B., Massaquoi, T., Gandi, R., Joseph, S., Osman, H. K., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001997 · Cited by 165
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Lubich, C., Allacher, P., de la Rosa, M., Bauer, A., Prenninger, T., Horling, F. M., Siekmann, J., Oldenburg, J., Scheiflinger, F., & Reipert, B. M. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1961-x · Cited by 164
Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting
Gupta, U. D., & Jain, N. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.018 · Cited by 162
New targets and delivery systems for antifungal therapy
Walsh, T. J., Viviani, M.-A., Arathoon, E., Chiou, C., Ghannoum, M., Groll, A. H., & Odds, F. C. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.335.347 · Cited by 161
Glenn, G. M., Fries, L. F., Thomas, D. N., Smith, G., Kpamegan, E. P., Lu, H., Flyer, D. C., Jani, D., Hickman, S. P., & Piedra, P. A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv406 · Cited by 161
Effect of nanoparticles on the male reproductive system of mice
Yoshida, S., Hiyoshi, K., Ichinose, T., Takano, H., Oshio, S., Sugawara, I., Takeda, K., & Shibamoto, T. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00865.x · Cited by 159
Non-specific cellular uptake of surface-functionalized quantum dots
Kelf, T. A., Sreenivasan, V. K. A., Sun, J., Kim, E. J., Goldys, E. M., & Zvyagin, A. V. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/28/285105 · Cited by 158
KUO, Y., & SU, F. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.012 · Cited by 158
Dutta, T., Agashe, H. B., Garg, M., Balasubramanium, P., Kabra, M., & Jain, N. K. (2007) · Journal of drug targeting · doi:10.1080/10611860600965914 · Cited by 157
Chen, H., Wang, L., Yeh, J., Wu, X., Cao, Z., Wang, Y. A., Zhang, M., Yang, L. P. H., & Mao, H. Z. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.036 · Cited by 151
Nanotechnology and vaccine development
Kim, M.-G., Park, J. Y., Shon, Y., Kim, G., Shim, G., & Oh, Y. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.06.002 · Cited by 151
Nanotechnology and the Treatment of HIV Infection
Parboosing, R., Maguire, G. E. M., Govender, P., & Kruger, H. G. (2012) · Viruses · doi:10.3390/v4040488 · Cited by 149
Self-citationC3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase
Andersson, J., Ekdahl, K. N., Larsson, R. L., Nilsson, U., & Nilsson, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5786 · Cited by 148
Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery
Ochekpe, N., Olorunfemi, P., & Ngwuluka, N. C. (2009) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v8i3.44547 · Cited by 147
Bengtsson, K. L., Song, H., Stertman, L., Liu, Y., Flyer, D. C., Massare, M. J., Xu, R.-H., Zhou, B., Lu, H., Kwilas, S. A., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.033 · Cited by 144
Inhibition effect of silver nanoparticles on herpes simplex virus 2
Hu, R., Li, S. R., Kong, F. J., Hou, R., Guan, X. L., & Guo, F. (2014) · Genetics and Molecular Research · doi:10.4238/2014.march.19.2 · Cited by 139
Nanostructures for the Inhibition of Viral Infections
Szunerits, S., Barras, A., Khanal, M., Pagneux, Q., & Boukherroub, R. (2015) · Molecules · doi:10.3390/molecules200814051 · Cited by 134
Anti-HIV-1 nanotherapeutics: promises and challenges for the future
Mahajan, S. D., Law, W., Aalinkeel, Reynolds, Nair, Sykes, Yong, K., Roy, Prasad, P. N., & Schwartz, S. A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s25871 · Cited by 134
Biodegradable nanoparticles for intracellular delivery of antimicrobial agents
Xie, S., Tao, Y., Pan, Y., Qu, W., Cheng, G., Huang, L., Chen, D., Wang, X., Liu, Z., & Yuan, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.034 · Cited by 131
Mohammad, A. K., & Reineke, J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300559v · Cited by 130
McGowan, I., Gomez, K., Bruder, K., Febo, I. L., Chen, B. A., Richardson, B. A., Husnik, M. J., Livant, E., Price, C. F., & Jacobson, C. E. (2011) · AIDS · doi:10.1097/qad.0b013e328346bd3e · Cited by 126
Kaushik, A. K., Jayant, R. D., Nikkhah-Moshaie, R., Bhardwaj, V., Roy, U. B., Huang, Z., Ruiz, A., Yndart, A., Atluri, V. S. R., El‐Hage, N., et al. (2016) · Scientific Reports · doi:10.1038/srep25309 · Cited by 123
Progress in antiretroviral drug delivery using nanotechnology
Rohan, L. C., & Mallipeddi (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s7681 · Cited by 122
Lipid based particulate formulations for the delivery of antigen
Copland, M. J., Rades, T., Davies, N. M., & Baird, M. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01315.x · Cited by 118
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection
Steinbach, J. M., Weller, C. E., Booth, C. J., & Saltzman, W. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.008 · Cited by 113
Moreno‐Fernandez, M. E., Zapata, W., Blackard, J. T., Franchini, G., & Chougnet, C. A. (2009) · Journal of Virology · doi:10.1128/jvi.01352-09 · Cited by 112
Sustained-release nanoART formulation for the treatment of neuroAIDS
Jayant, R. D., Atluri, V. S. R., Agudelo, M., Sagar, V., Kaushik, A. K., & Nair, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s76517 · Cited by 111
Barik, S. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-104 · Cited by 111
Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics
McNeil, S. E. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_1 · Cited by 109
Gerrity, D. W., Ryu, H., Crittenden, J. C., & Abbaszadegan, M. A. (2008) · Journal of Environmental Science and Health Part A · doi:10.1080/10934520802177813 · Cited by 109
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Sawaengsak, C., Mori, Y., Yamanishi, K., Mitrevej, A., & Sinchaipanid, N. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0058-7 · Cited by 105
Lucey, D. R., & Gostin, L. O. (2016) · JAMA · doi:10.1001/jama.2016.0904 · Cited by 104
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Aciclovir
Arnal, J., González‐Álvarez, I., Bermejo, M., Amidon, G. L., Junginger, H. E., Kopp, S., Midha, K. K., Shah, V. P., Stavchansky, S., Dressman, J., et al. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21392 · Cited by 102
Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir
Al‐Dhubiab, B. E., Nair, A. B., Kumria, R., Attimarad, M., & Sreeharsha, N. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.10.045 · Cited by 98
Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination
Sjögren, M. H. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.012 · Cited by 97
Chiappetta, D. A., Facorro, G., Rubin de Celis, E., & Sosnik, A. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.017 · Cited by 96
Moretton, M. A., Glisoni, R. J., Chiappetta, D. A., & Sosnik, A. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.05.016 · Cited by 96
Innovative nanotechnologies for the delivery of oligonucleotides and siRNA
Toub, N., Malvy, C., Fattal, E., & Couvreur, P. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.093 · Cited by 96
Tan, M., & Jiang, X. (2012) · Nanomedicine · doi:10.2217/nnm.12.62 · Cited by 96
Lebre, F., Borchard, G., Faneca, H., de Lima, M. C. P., & Borges, O. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00707 · Cited by 94
Role of nanotechnology in HIV/AIDS vaccine development
Liu, Y., & Chen, C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.010 · Cited by 93
Potential of magnetic nanoparticles for targeted drug delivery
Wei, K., Yang, H., Hua, Liu, & Huang (2012) · Nanotechnology Science and Applications · doi:10.2147/nsa.s35506 · Cited by 89
Sialylneolacto-N-tetraose c (LSTc)-bearing Liposomal Decoys Capture Influenza A Virus
Hendricks, G. L., Weirich, K. L., Viswanathan, K., Li, J., Shriver, Z. H., Ashour, J., Ploegh, H. L., Kurt‐Jones, E. A., Fygenson, D. K., Finberg, R. W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437202 · Cited by 89
Electrochemical Biosensors for Early Stage Zika Diagnostics
Kaushik, A. K., Tiwari, S., Jayant, R. D., Vashist, A., Nikkhah-Moshaie, R., El‐Hage, N., & Nair, M. G. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.10.001 · Cited by 89
Cited by
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiss, C., Carriere, M., Fusco, L., Capua, I., Regla-Nava, J. A., Pasquali, M., Scott, J. A., Vitale, F., Unal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 601
Metal Oxide Nanoparticles as Biomedical Materials
Nikolova, M. P., & Chavali, M. S. (2020) · Biomimetics · doi:10.3390/biomimetics5020027 · Cited by 510
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
A review on MnZn ferrites: Synthesis, characterization and applications
Thakur, P., Chahar, D., Taneja, S., Bhalla, N., & Thakur, A. (2020) · Ceramics International · doi:10.1016/j.ceramint.2020.03.287 · Cited by 451
Application of Light Scattering Techniques to Nanoparticle Characterization and Development
Carvalho, P. M., Felício, M. R., Santos, N. C., Gonçalves, S., & Domingues, M. M. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00237 · Cited by 402
Metadata
- Authors
- Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R.
- Venue
- Therapeutic Advances in Infectious Disease
- Publisher
- SAGE Publications
- Published
- 2017-07
- Volume
- 4
- Issue
- 4
- Pages
- 105-131
- ISSN
- 2049-9361 (ISSN-L)
- 2049-937X
- OpenAlex
- W2735723920
- Cited by
- 360
- References
- 257
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.